Cyclo Therapeutics, Inc. (CYTH) has a consensus analyst rating of Hold, based on 3 analysts covering the stock. Of those, 1 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for CYTH is $0.95, representing a +31.8% upside from the current price of $0.7206. Price targets range from a low of $0.95 to a high of $0.95.
